Profil
Nathan Chen is currently the Vice President of Regulatory Affairs at LianBio.
Prior to this, he worked as the Head of Immunology & Inflammation at GSK Plc from 2018 to 2020 and as the Director of Regional Clinical Development at Boehringer Ingelheim Corp.
He holds graduate degrees from Purdue University, Rensselaer Polytechnic Institute, and the State University of New York at Albany.
Aktive Positionen von Nathan Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| LIANBIO | General Counsel | 01.02.2020 |
Ehemalige bekannte Positionen von Nathan Chen
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.02.2020 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Ausbildung von Nathan Chen
| Purdue University | Graduate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
| State University of New York at Albany | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| LIANBIO | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
